扶正抗癌方联合化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响  

Effects of Fuzheng Kang'ai prescription combined with chemotherapy on serum tumor markers in patients with advanced non small cell lung cancer

作　　者：张公正 

机构地区：[1]河南省平顶山市第二人民医院,平顶山467000

出　　处：《陕西中医》2017年第7期885-886,共2页Shaanxi Journal of Traditional Chinese Medicine

摘　　要：目的:探究中西医结合治疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响。方法:选取90例非小细胞肺癌患者,随机分成对照组和观察组各45例,对照组采用单纯化疗治疗,观察组采用中西医结合治疗,对两组患者的治疗效果、治疗后2、4、6个月的血清肿瘤标志物的变化情况进行检测统计。结果:观察组的总有效率为93.3%,显著高于对照组的71.1%,差异比较具有统计学意义(P<0.05);治疗后两组患者的CA-125、CEA、NSE、CYFRA21-1水平均显著降低,且观察组相比对照组更低(P<0.05)。结论:扶正抗癌方联合化疗对晚期非小细胞肺癌患者效果值得肯定,能够显著降低血清肿瘤标志物水平。Objective：To explore the effect of integrated traditional Chinese and western medicine on serum tumor markers in patients with advanced non-small cell lung cancer.Methods：90cases of non-small cell lung cancer patients were randomly divided into control group and observation group,45 cases in each group,the control group were treated by chemotherapy treatment,observation group were treated with combined therapy of Fuzheng Kang＇ai prescription,in the treatment of two groups of patients,after 2 months,4 months and 6 months were to detected statistical changes.Results：The curative effect evaluation showed that the total effective rate of observation group was 93.3%,significantly higher than 71.1%in the control group,the difference was statistically significant（P〈0.05）;two groups after the treatment,CA-125,CEA,NSE and CYFRA21-1levels were significantly decreased,and the observation group was lower compared to the control group（P〈0.05）.Conclusion：The combined treatment of Fuzheng Kang＇ai prescription for patients with advanced non-small cell lung cancer is worthy of recognition,can significantly reduce the level of serum tumor markers.

关 键 词：肺肿瘤/中西医结合疗法 化疗 @扶正抗癌方 

分 类 号：R734.2[医药卫生—肿瘤]